Response to nilotinib as a first-line treatment for metastatic gastrointestinal stromal tumors.
Schlemmer
Marcus
M
Department of Internal Medicine III-Hematology/Oncology, University Hospital Munich-Campus Grosshadern, Munich, Germany. Marcus.Schlemmer@med.uni-muenchen.de
Schinwald
Nicole
N
Bruns
Christiane
C
Berger
Frank
F
Reichardt
Peter
P